Subscribe
The latest psychology and neuroscience discoveries.
My Account
  • Mental Health
  • Social Psychology
  • Cognitive Science
  • Psychopharmacology
  • Neuroscience
No Result
View All Result
PsyPost
PsyPost
No Result
View All Result
Home Exclusive Mental Health

New non-invasive method can detect Alzheimer’s disease early

by Northwestern University
December 22, 2014
in Mental Health
Photo credit: NIMH

Photo credit: NIMH

Share on TwitterShare on Facebook
Follow PsyPost on Google News

No methods currently exist for the early detection of Alzheimer’s disease, which affects one out of nine people over the age of 65. Now, an interdisciplinary team of Northwestern University scientists and engineers has developed a noninvasive MRI approach that can detect the disease in a living animal. And it can do so at the earliest stages of the disease, well before typical Alzheimer’s symptoms appear.

Led by neuroscientist William L. Klein and materials scientist Vinayak P. Dravid, the research team developed an MRI (magnetic resonance imaging) probe that pairs a magnetic nanostructure (MNS) with an antibody that seeks out the amyloid beta brain toxins responsible for onset of the disease. The accumulated toxins, because of the associated magnetic nanostructures, show up as dark areas in MRI scans of the brain.

This ability to detect the molecular toxins may one day enable scientists to both spot trouble early and better design drugs or therapies to combat and monitor the disease. And, while not the focus of the study, early evidence suggests the MRI probe improves memory, too, by binding to the toxins to render them “handcuffed” to do further damage.

“We have a new brain imaging method that can detect the toxin that leads to Alzheimer’s disease,” said Klein, who first identified the amyloid beta oligomer in 1998. He is a professor of neurobiology in the Weinberg College of Arts and Sciences.

“Using MRI, we can see the toxins attached to neurons in the brain,” Klein said. “We expect to use this tool to detect this disease early and to help identify drugs that can effectively eliminate the toxin and improve health.”

With the successful demonstration of the MRI probe, Northwestern researchers now have established the molecular basis for the cause, detection by non-invasive MR imaging and treatment of Alzheimer’s disease. Dravid introduced this magnetic nanostructure MRI contrast enhancement approach for Alzheimer’s following his earlier work utilizing MNS as smart nanotechnology carriers for targeted cancer diagnostics and therapy. (A MNS is typically 10 to 15 nanometers in diameter; one nanometer is one billionth of a meter.)

Details of the new Alzheimer’s disease diagnostic are published today (Dec. 22) by the journalNature Nanotechnology. Klein and Dravid are co-corresponding authors.

The emotional and economic impacts of Alzheimer’s disease are devastating. This year, the direct cost of the disease in the United States is more than $200 billion, according to the Alzheimer’s Association’s “2014 Alzheimer’s Disease Facts and Figures.” By the year 2050, that cost is expected to be $1.1 trillion as baby boomers age. And these figures do not account for the lost time of caregivers.

This new MRI probe technology is detecting something different from conventional technology: toxic amyloid beta oligomers instead of plaques, which occur at a stage of Alzheimer’s when therapeutic intervention would be very late. Amyloid beta oligomers now are widely believed to be the culprit in the onset of Alzheimer’s disease and subsequent memory loss.

In a diseased brain, the mobile amyloid beta oligomers attack the synapses of neurons, destroying memory and ultimately resulting in neuron death. As time progresses, the amyloid beta builds up and starts to stick together, forming the amyloid plaques that current probes target. Oligomers may appear more than a decade before plaques are detected.

“Non-invasive imaging by MRI of amyloid beta oligomers is a giant step forward towards diagnosis of this debilitating disease in its earliest form,” said Dravid, the Abraham Harris Professor of Materials Science and Engineering at the McCormick School of Engineering and Applied Science.

There is a major need for what the Northwestern research team is doing — identifying and detecting the correct biomarker for new drug discovery. Despite extraordinary efforts, no effective drugs exist yet for Alzheimer’s disease.

“This MRI method could be used to determine how well a new drug is working,” Dravid said. “If a drug is effective, you would expect the amyloid beta signal to go down.”

The nontoxic MRI probe was delivered intranasally to mouse models with Alzheimer’s disease and control animals without the disease. In animals with Alzheimer’s, the toxins’ presence can be seen clearly in the hippocampus in MRI scans of the brain. No dark areas, however, were seen in the hippocampus of the control group.

The ability to detect amyloid beta oligomers, Klein said, is important for two reasons: amyloid beta oligomers are the toxins that damage neurons, and the oligomers are the first sign of trouble in the disease process, appearing before any other pathology.

Klein, Dravid and their colleagues also observed that the behavior of animals with Alzheimer’s improved even after receiving a single dose of the MRI probe.

“While preliminary, the data suggests the probe could be used not only as a diagnostic tool but also as a therapeutic,” said Kirsten L. Viola, a co-first author of the study and a research manager in Klein’s laboratory.

Along with the studies in live animals, the research team also studied human brain tissue from Northwestern’s Cognitive Neurology and Alzheimer’s Disease Center. The samples were from individuals who died from Alzheimer’s and those who did not have the disease. After introducing the MRI probe, the researchers saw large dark areas in the Alzheimer brains, indicating the presence of amyloid beta oligomers.

The title of the paper is “Towards non-invasive diagnostic imaging of early-stage Alzheimer’s disease.”

In addition to Klein, Dravid and Viola, other authors of the paper are from Northwestern University; Universidade Federal de Santa Catarina, Brazil; Illinois Mathematics and Science Academy; and North Shore University Health Systems.

TweetSendScanShareSendPinShareShareShare

RELATED

Study links air pollution to increased dementia risk in U.S. residents
Dementia

Study links air pollution to increased dementia risk in U.S. residents

March 29, 2024

A decade-long U.S. study found a slight increase in dementia risk among people exposed to PM2.5 air pollution, particularly from agriculture and wildfires. The research emphasizes the need for targeted air quality interventions to reduce dementia's burden.

Read more
Psychiatrists detail a harrowing case of internet-induced erotomania
Mental Health

Psychiatrists detail a harrowing case of internet-induced erotomania

March 28, 2024

A case study in BMC Psychiatry describes a 70-year-old woman who developed erotomania, a delusional disorder, after falling victim to an online romance fraud, highlighting the psychological risks associated with internet usage and the need for awareness in mental health contexts.

Read more
Mothers who feel unworthy of being loved have less supportive responses to child distress
Anxiety

How can I stop overthinking everything? A clinical psychologist offers solutions

March 28, 2024

Many of us find ourselves trapped in a relentless cycle of rumination and overthinking, often struggling to find an escape. Here are some strategies to break free.

Read more
Retired fighters with better win-loss ratios tend to be more impulsive and to have slower cognitive processing speed
Mental Health

Retired fighters with better win-loss ratios tend to be more impulsive and to have slower cognitive processing speed

March 28, 2024

New research has found that retired professional fighters with better win-loss ratios exhibit greater impulsiveness, slower cognitive speeds, and reduced brain volumes in several areas, suggesting even successful fighters face adverse effects on brain health.

Read more
Chronic alcohol use is linked to impaired plasticity of brain inhibition networks, study suggests
Addiction

Chronic alcohol use is linked to impaired plasticity of brain inhibition networks, study suggests

March 28, 2024

Brain stimulation was found to enhance inhibitory control in healthy adults but failed to improve inhibitory control in those with alcohol use disorder, suggesting chronic alcohol use alters the brain's responsiveness to neuromodulation.

Read more
19% of antidepressant users report sexual problems connected to the treatment
Depression

19% of antidepressant users report sexual problems connected to the treatment

March 27, 2024

A study published in the Journal of Affective Disorders Reports found that 19% of antidepressant users without prior sexual problems experienced sexual dysfunction related to their medication, highlighting the impact of side effects on treatment continuation and patient quality of life.

Read more

SUBSCRIBE

Go Ad-Free! Click here to subscribe to PsyPost and support independent science journalism!

STAY CONNECTED

RECENT

Astronauts surprisingly good at judging distances without gravity

Experiments show political affiliation trumps fair play in moral evaluations

Stipends for doctoral students of psychology have not kept pace with cost of living in the U.S., study finds

Kids in ethnically diverse classrooms exhibit superior theory of mind abilities

Cross-cultural research reveals universal bias towards simple rhythmic ratios in music

Here’s why no one can accurately predict how financial markets will behave

Study links air pollution to increased dementia risk in U.S. residents

Pinpointing the psychological factors linked to men’s misjudgments of women’s sexual interest

  • Contact us
  • Privacy policy
  • Terms and Conditions
[Do not sell my information]

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

Subscribe
  • My Account
  • Cognitive Science Research
  • Mental Health Research
  • Social Psychology Research
  • Drug Research
  • Relationship Research
  • About PsyPost
  • Contact
  • Privacy Policy